Thus, intrathecally administered BDNF in patients of amyotrophic lateral sclerosis (ALS) did not show significant effects on motor function and survival [1] or autonomic nervous system function [2]. This evidence concerns the gene BDNF and amyotrophic lateral sclerosis.